Abstract
Susceptibility of lymphoma cells (Daudi, HD-Mar) to Newcastle disease virus toxicity was found to be higher than that of lymphoblastoid cells (Milstein) and of resting peripheral blood lymphocytes (PBL). Phytohemagglutinin- and/or pokeweed-mitogen-activated PBL however, exhibited, elevated sensitivity, similar to that of lymphoma cells. The level of cytotoxicity was monitored by cell viability, inhibition of DNA synthesis and release of51Cr. When Daudi cells were mixed with PBL they were significantly more sensitive to the killing effect of the virus (70% mortality compared to 30% 30 h after infection,P<0.05). The degree of sensitivity to viral cytotoxicity was unrelated to the efficacy of adsorption, which was similar for all cell lines as shown by immunofluorescent staining and flow cytometry. Also an influenza strain A/PR/8/34 (H1N1) adsorbed but did not affect the viability of any of the cells tested. Our results demonstrate that Newcastle disease virus caused preferential damage to lymphoma cells as compared to non-cancerous normal cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- BCECF :
-
2′, 7′-bis-(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester
- FCS :
-
fetal calf serum
- PBS :
-
phosphate-buffered saline
- NDV :
-
Newcastle disease virus
- PBL :
-
Peripheral blood lymphocytes
- Ro :
-
Mesogenic (medium virulent) NDV strain Roakin/46 V-109 NJ
- TNF :
-
tumor necrosis factor
References
Ben-Bassat H, Mitrani-Rosenbaum S, Gamliel H, Naparstek E, Leizerowitz R, Korkesh A, Sage M, Voss R, Kohn G, Polliack A (1980) Establishment in continuous culture of a new T-lymphoid cell line (HD-Mar) from a patient with Hodgkin's lymphoma. Int J Cancer 25:583–590
Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21 [Suppl 97]:77–89
Crumpton MJ, Augh J, Green NM, Maino VC (1976) Surface membrane events following activation by lectins and calcium ionophore. In: Oppenheimer JJ, Rosenstreich DL (eds) Mitogens in immunobiology. Academic Press New York, pp 85–101
Csatary LK, Eckhardt S, Bukosza I, Czegledi F, Fenyvesl C, Gergely P, Bodey B, Csatary CM (1993) Attenuated veterinary virus for the treatment of cancer. Cancer Detect Prevent 17:619–627
Danilovs JA, Ayouba G, Terasaki PI (1980) B lymphocyte isolation by thrombin-nylon wool. In: Teraski PI (ed) Histocompatibility testing. UCLA Tissue Typing Laboratory, Los Angeles, Calif., pp 287–292
Grunwald-Beard L, Gamleil H, Parag G, Vedantham S, Zakay-Rones Z (1991) Burkitt lymphoma Daudi cells killing by ultraviolet inactivated vaccinia virus. J Cancer Res Clin Oncol 117:561–567
Hanks JH, Wallace J (1958) Determination of cell viability. Proc Exp Biol Med 98:188–190
Jones EY, Stuart DI, Walker NPC (1989) Structure of tumor necrosis factor. Nature 338:225–228
Kinter AL, Poli G, Fox L, Hardy E, Fauci AS (1995) HIV replication in IL-2 stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol 154:2448–2459
Klein E, Klein G, Nadkarni JS, Wigzell H, Clifford P (1968) Surface IgM-kappa specificity on Burkitt lymphoma cell in-vivo and derived cultures lines. Cancer Res 28:1300–1310
Klein G (1979) Lymphoma development in mice and human diversity of initiation is followed by convergent cytogenetic evaluation. Proc Natl Acad Sci USA 76:2442–2449
Larzlo G, Hatcock KS, Dickler HB, Hodes RJ (1993) Characterization of a novel cell surface molecule expressed on subpopulations of activated T and B cells. J Immunol 150:5252–5262
Lieberman AP, Pitha PM, Shin HS, Shin ML (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 86:6348–6352
Lopez-Cepero M, Garcia-Sanz JA, Herbert L, Riley R, Handel ME, Podack ER, Lopez DM (1994) Soluble and membrane-bound TNF are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets. J Immunol 152:3333–3341
Lorence RM, Rood PA, Kelley KW (1988) Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor and augmentation of its cytotoxicity. J Natl Cancer Inst 80:1305–1312
Lorence RM, Katbig BB, Reiehard KW, Reyes HM, Phuangsab A, Sassetti MD, Walter RJ, Peeples ME (1994) Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy. Cancer Res 54:4117–4121
Pasternak CA (1987) Viruses as toxins. Arch Virol 93:169–184
Pasternak CA, Adler GM, Bashford CL, Buckley CD, Micklem KJ, Patal K (1985) Cell damage by viruses, toxines and complement: common features of pore-formation and its inhibition by Ca++. Biochem Soc Symp 50:247–264
Polliack A, Touraine JL, Harven E de, Lampen N, Hadden JW (1975) Scanning electron microscopy of mitogen-transformed human lymphocytes Isr J Med Sci 11:1285–1298
Schild H, Von Hoegen P, Schirrmacher V, (1989) Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation. Cancer Immunol Immunother 28:22–28
Schirrmacher V, Ahlert T, Heicappell R, Appelhans B, Von Hoegen P (1986) Successful application of nononcogenic viruses for antimetastatic cancer immunotherapy. Cancer Rev 5:1–31
Semenzato G (1990) Tumor necrosis factor a cytokine with multiple biologicals activities. Br J Cancer 61:354–361
Shlomi Y, Zakay-Rones Z (1989) Sensitivity of Burkitt lymphoma cells to inactive influenza virus. J Cancer Res Clin Oncol 115:61–66
Slosaris M, Levy B, Katz E, Levy R, Zakay-Rones Z (1989) Elevated virulence of Newcastle disease virus strains following serial passages in kidney cells in vitro. Avian Dis 33:248–253
Snir I (1988) Oncolytic activity of influenza viruses (active and inactive) on cancer cells. MSc thesis accepted by the Hebrew University Hadassah Med School
Spira G, Silvian I, Zakay-Rones Z (1977) Iodination of Newcastle disease virus envelope proteins with lacto-peroxidase. Isr J Med Sci 13:76–79
Sullivan JJ, Barry DW, Lucas SJ, Albreict P (1975) Measles infection of human mononuclear cells. J Exp Med 142:773–784
Tzadok-David Y, Metzkin-Eizenberg M, Zakay-Rones Z (1995) The effect of a mesogenic and a lentogenic Newcastle disease virus strain on Burkitt lymphoma Daudi cells. J Cancer Res Clin Oncol 121:169–174
Von Hoegen P, Zawatzky R, Schirrmacher V (1990) Modification of cancer cells by a low dose of NDV. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon alpha/beta. Cell Immunol 126:80–90
Weil-Hillman G, Zakay-Rones Z (1985) Arrest of Daudi cell growth by inactive influenza virus in vitro. Scanning Electron Microsc 4:1679–1686
Weil-Hillman G, Zakay-Rones Z (1987) Inhibition of Daudi tumor formation by inactive influenza virus in nude mouse model. Cancer J 1:208–212
Weil-Hillman G, Gamliel G, Friedman A, Zakay-Rones Z (1985) Visualization of the fate of inactive influenza viruses in Daudi cells in EM. Scanning Electron Microsc 4:1687–1693
Wheelock F, Toy ST (1973) Participation of lymphocytes in viral infection. Adv Immunol 16:123–184
Woodruff JF, Woodruff JJ (1975) Lymphocytes receptors for myxoviruses and paramyxoviruses. J Immunol 112:2176–2174
Zakay-Rones Z, Bernkopf H (1964) Effect of active and ultraviolet irradiated vaccinia virus on the development of Shay leukemia in rats. Cancer Res 24:373–378
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bar-Eli, N., Giloh, H., Schlesinger, M. et al. Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells. J Cancer Res Clin Oncol 122, 409–415 (1996). https://doi.org/10.1007/BF01212880
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01212880